发布时间:2019-08-04 11:48 原文链接: Hypoxiaandp53intheCardiovascularsystem

Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not induce p53-dependent cell cycle arrest, suggesting that p53 activity is differentially regulated by these two stresses. Hypoxia induces p53 protein accumulation, but in contrast to DNA damage, hypoxia fails to induce endogenous downstream p53 effector mRNAs and proteins, such as p21, Bax, CIP1, WAF1 etc. Hypoxia does not inhibit the induction of p53 target genes by ionizing radiation, indicating that p53-dependent transactivation requires a DNA damage-inducible signal that is lacking under hypoxic treatment alone. The phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53. At the molecular level, DNA damage induces the interaction of p53 with the transcriptional activator p300 as well as with the transcriptional corepressor mSin3A. In contrast, hypoxia primarily induces an interaction of p53 with mSin3A, but not with p300.

Contributor:

REFERENCES: Appella E, Anderson CW. (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 268(10):2764-72. Review. Asher G, et al., (2002) NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A. 5;99(5):3099-104. Blagosklonny MV. (2001) Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors. Oncogene. 20(3):395-8. Review. Freedman SJ, et al., (2002) Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A 99(8):5367-72. Koumenis C, et al., (2001) Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 21(4):1297-310. Minet E, et al., (1999) Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 460(2):251-6. Ogawara Y et al., (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 277(24):21843-50. Ravi R, et al., (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14(1):34-44. Sakaguchi K, et al.,. (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem. 275(13):9278-83. Suzuki H, et al., (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene. 20(41):5779-88.


相关文章

SCIEX临床质谱新品重磅上市|Citrine™TripleQuad™System

SCIEX新一代液相色谱串联质谱检测系统Citrine™TripleQuad™System(注册证编号:国械注进20232220176)重磅发布!感谢您的一路同行,在未来,SCIEX将继续秉承“倾听客......

新加坡癌症科学研究所的研究者们发表重磅综述

抑癌基因P53是一种主要的转录因子,参与多种细胞功能的调节。在癌症中,P53抑制细胞的增殖,以应对各种刺激,包括DNA损伤、营养缺乏、缺氧、过度增殖信号,从而防止肿瘤的形成。因此,它被恰如其分地称为“......

190亿!赛默飞收购欧洲IVD巨头

近日,服务科学领域的全球领导者赛默飞世尔科技(以下简称赛默飞)宣布,在达成收购意向两个月之后,赛默飞以28亿美元、折合人民币约190亿元的价格,完成了对TheBindingSiteGroup的全现金收......

施普林格·自然与TheLens达成合作

11月15日,施普林格·自然和TheLens平台宣布结成重要的合作伙伴关系,以更深入地揭示学术研究和数据如何能通过经济和社会成效,加速推动创新的问题解决方式。通过将科学、投资和企业领域的开放数据更好地......

CancerRes:叛变了?最强抑癌基因p53竟会促进肝癌发展

自1979年被发现以来,p53基因一直是肿瘤学研究的焦点之一。在Pubmed数据库中用p53为关键词搜索,可以找到超过十万篇文献。在Nature杂志2017年的一项统计中,p53基因以绝对优势位列过去......

“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段

万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......

上海药物所提出USP7降解剂作为p53突变型癌症的治疗策略

P53是一种肿瘤抑制蛋白,属于最早发现的肿瘤抑制基因之一,但在超过一半的人类癌症中均出现p53的突变。突变型p53丧失了自身的抑癌功能,并影响野生型p53蛋白、抑制其功能,进一步促进肿瘤的生成。因此,......

青源峰达太赫兹在国际顶级期刊《TrendsinBiotechnology》发文

青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......

firstinclass胃癌一线疗法获FDA突破性疗法

安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......

GeneDev:研究发现抗癌基因有助于控制“跳跃”基因

所有肿瘤中约有一半具有基因p53的突变,通常负责抵御癌症。现在,UT西南大学的科学家发现了p53在对抗肿瘤中的新作用:防止逆转座子或“跳跃基因”在人类基因组中跳跃。研究小组发现,在p53缺失或突变的细......